Structure (Divalproex Sodium Extended Release Tablets Usp 1)
Divalproex Sodium Tablet, Extended Release
Product Images NDC 65162-757
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 65162-757). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Divalproex Sodium Extended Release Tablets Usp 2)
Figure 2 (Divalproex Sodium Extended Release Tablets Usp 3)
The text is a graph displaying the reduction in CPS rate for patients taking high and low dose Divalproex Sodium medication. The graph shows a 100% reduction in CPS rate for patients taking high dose medication and a 50% reduction for patients taking low dose medication. The graph also shows the percentage of patients with improvement, no change, or worsening symptoms.*
Figure 3 (Divalproex Sodium Extended Release Tablets Usp 4)
250 mg 100 Count (Divalproex Sodium Extended Release Tablets Usp 5)
500 mg 100 Count (Divalproex Sodium Extended Release Tablets Usp 6)
This appears to be a combination of random text, codes, and drug names. It is not a useful description.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
